You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Claforan In Dextrose 5% In Plastic Container, and what generic alternatives are available?

Claforan In Dextrose 5% In Plastic Container is a drug marketed by Sterimax and is included in one NDA.

The generic ingredient in CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER is cefotaxime sodium. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cefotaxime sodium profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What are the global sales for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER?
Summary for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
HÃ¥kan HanbergerPhase 4
University Medical Center GroningenPhase 4
University of California, San FranciscoPhase 1

See all CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sterimax CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-002 May 20, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sterimax CLAFORAN IN DEXTROSE 5% IN PLASTIC CONTAINER cefotaxime sodium INJECTABLE;INJECTION 050596-004 May 20, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.